Skip to main content
Monday
October 20, 2025
Sign In
Subscribe
Latest
Economy
Banking
Stocks
Industry
Analysis
Bazaar
RMG
Corporates
Aviation
Videos
TBS Today
TBS Stories
TBS World
News of the day
TBS Programs
Podcast
Editor's Pick
World+Biz
Features
Panorama
The Big Picture
Pursuit
Habitat
Thoughts
Splash
Mode
Tech
Explorer
Brands
In Focus
Book Review
Earth
Food
Luxury
Wheels
Subscribe
Get the Paper
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Bangladesh
Supplement
Infograph
Explainer
Archive
Gallery
Long Read
Interviews
Offbeat
Magazine
Climate Change
Health
Cartoons
বাংলা
MONDAY,
OCTOBER 20, 2025
FDA
FDA
FDA expands use of remdesivir to patients with high risk of hospitalization
US FDA may approve Covid-19 booster without outside advisory panel opinion -CNN
Pfizer asks FDA to OK Covid-19 booster shots for all adults
Moderna says FDA needs more time to complete review of its Covid-19 shot for adolescents
US FDA authorizes first Covid-19 shot for young kids
US FDA advisers back Pfizer/BioNTech Covid-19 vaccine for children
FDA says benefits outweigh risks for Pfizer/BioNTech Covid-19 vaccine in children
Second J&J Covid shot gets expert backing; FDA looking at lowering age for Pfizer booster
US FDA gives marketing nod to an e-cigarette for the first time
Merck seeks first US FDA authorisation for Covid-19 tablet
US could authorize Pfizer Covid-19 shot for kids age 5-11 in October -sources
Are Covid boosters needed? FDA vaccine advisers wrestle with a thorny issue
“If we can develop skilled manpower, we can enter any market of the world”
Show More